Identification of a novel negative regulatory element on the hepatitis B virus S-(+)-strand

Abstract

In this study, we scanned the whole hepatitis B virus (HBV) genome for the identification of potential regulatory elements located on the S-(+)-strand. With pCDNA3.1-HBV1.3 as template which contains 1.3-fold HBV whole genome, HBV fragments were amplified by PCR methods, and then inserted into the upstream of a heterologous luciferase reporter vector (pGL3control) in antisense orientation, allowing the HBV expression from the S-(+)-strand. We found that the reporter plasmid containing nt 509-1(3182)-2639 of HBV inhibited luciferase gene transcription and expression in HepG2 cells. Our results strongly suggested that nt 453-250 of HBV may act as a novel negative regulatory element, which has not been reported before. Serial deletion analyses further indicated that nt 453-250 sequence of HBV genome would be the minimal sequence essential for the inhibitory effect of the novel negative regulatory element.

MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells

“…The expression vector of pcDNA3.1-HBx was constructed by inserting HBx DNA fragments into pcDNA3.1 vector [ 17 ]. The 1.3 fold HBV genome (genotype C) fragment was amplified from pGEM-HBV1.3, and the amplified 1.3 fold HBV genome fragments was cloned into pcDNA3.1 plasmid for the construction of pcDNA3.1-HBV plasmid [ 18 ]. The expression vectors of pcDNA3.1-PTEN, pcDNA3.1-cylcin G1, and pcDNA3.1-c-myc were purchased from Genepharma (Shanghai, China).…”